RVMD Today - Aug 09: Demand Drives Price Up
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
RVMD Today - Aug 09: Demand Drives Price Up
-
Letto da:
-
Di:
Here’s the scoop. RVMD saw some nice movement today, and honestly, it’s been a rollercoaster lately. There’s been a lot of talk about their drug, Daraxonrasib, really picking up steam. Apparently, there’s a growing demand for it, which is definitely giving the stock a boost. I mean, after some tough losses recently, it’s like the market’s finally giving them a little love.
Now, let’s get into the why. Assenagon Asset Management jumped in and bought a hefty chunk of shares—over 200,000 of them. That’s a solid vote of confidence right there. Meanwhile, J.P. Morgan’s keeping the faith too, maintaining a buy rating and even raising their target price to $227. So, folks are clearly seeing potential here. On the flip side, Sei Investments decided to cut down their holdings, which is a bit of a mixed bag, but the overall vibe today was pretty positive.
One thing that’s worth mentioning is that the demand for Daraxonrasib seems to be a game-changer for them. As more buzz builds around it, it could really shake things up for RVMD in the coming months.
Alright, that’s the scoop for today! Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione